Movement Alert|Ali Health Rises 3.21% in Regular Trading, Sector Rally and Strategic Partnership Fuel Oversold Rebound

Market Focus06-02

On June 2, Ali Health rose 3.21% in regular trading, trading at HK$3.87/share, with trading volume of HK$182 million, rebounding after consecutive post-earnings declines.

On the news front, the company recently signed a strategic cooperation agreement with men's health leader Menarini, jointly releasing the China Men's Health and Medication Trends Insight Report. The two parties will collaborate through a model combining original drug launches, scientific medication guidance, and digital health management to drive business synergies.

Simultaneously, the broader Internet and Direct Marketing Retail sector rallied strongly, with BABA-W up 5.29%, Meituan-W up 8.37%, JD-SW up 4.0%, and PA Good Doctor up 4.06%. The sector-wide linkage effect provided rebound momentum for Ali Health, which had been under sustained pressure after multiple investment banks collectively cut target prices following weaker-than-expected FY26 results, where second-half revenue growth of 7.6% significantly missed the market consensus of 13.8%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment